Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) for Enhancing Solubility and Stability of Poorly Water-Soluble Drugs: A Comprehensive Review
Year: 2026
Type: article
Abstract: Poor aqueous solubility remains one of the most significant challenges in oral and parenteral drug delivery, affecting the therapeutic efficiency, bioavailability, and clinical success of many modern pharmaceuticals.Lipid-based nanocarriers-particularly Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs)-have emerged as promising platforms to overcome these limitations due to their biocompatibility, scalability, and ability to improve solubility and stability.SLNs represent the first-generation solid lipid systems, offering controlled release and protection of labile drugs but suffering from low drug loading and drug expulsion due to crystalline transitions.NLCs, the second-generation improvement, incorporate a mixture of solid and liquid lipids, resulting in lessordered matrices capable of higher drug loading, minimized drug leakage, and enhanced stability.This review provides an in-depth analysis of the composition, preparation methods, characterization techniques, mechanisms of solubility enhancement, pharmaceutical applications, and limitations of SLNs and NLCs.Representative case studies of clinically relevant poorly water-soluble drugs are discussed.Emerging trends such as targeted lipid nanocarriers, stimuli-responsive systems, and industrial scalability are highlighted as future directions.
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7220950791
